Concurrent Technologies Plc
Keith Gill
"The market is treating Concurrent Technologies as a cyclical small-cap defense hardware maker with lumpy revenue and no competitive moat. This fundamentally misunderstands the business. The SOSA mandate is not a temporary procurement preference—it's a structural shift in how the US Department of Defense buys computing hardware, explicitly designed to break the vendor lock-in that protected incumbents for decades. Concurrent is not a company trying to compete with Curtiss-Wright on scale; it's a company that has positioned itself exactly where the procurement winds are blowing, with an entirely SOSA-compliant product portfolio, early access to the latest Intel and NVIDIA processors, and deepening relationships with global defense primes. The £145m in FY25 design wins alone—roughly 3x annual revenue—represents a revenue pipeline that will convert to orders and then to revenue over the next 7-10 years. This is not speculative; these are programs where Concurrent has already been selected. The balance sheet provides the ultimate safety net: £14.4m net cash, zero debt, and self-funding operations mean this company survives any macro environment. The Systems business is approaching an inflection point from loss-making to profitability, which alone could drive meaningful margin expansion at the group level. The Colchester factory expansion doubles capacity for minimal capital outlay, positioning the company to capture the demand that its design wins are creating. At 244p, the stock trades at approximately 26-31x forward earnings depending on FY26 outcome—not cheap, but reasonable for a company with this level of revenue visibility, balance sheet strength, and structural tailwind. The risk-reward is asymmetric: the downside is protected by the cash position and the installed base of long-lifecycle products, while the upside is driven by design win conversion, Systems profitability, and the multi-year defense spending upcycle. The market has not yet connected the dots between the SOSA mandate, the design win pipeline, and the earnings power that will emerge as these programs move into production. When they do, this stock re-rates significantly."
Overview
A deep value and contrarian analysis of Concurrent Technologies Plc (CNC.L), an AIM-listed designer and manufacturer of rugged embedded computing systems primarily serving defense primes. This analysis examines whether the market is underpricing a structural shift in defense procurement (SOSA mandate) and the company's growing design win pipeline, while the stock remains underfollowed and misunderstood by the broader market. Think of it as a small-cap defense electronics play sitting on a powder keg of multi-year revenue visibility, hiding in plain sight on London's junior market.
The Bear Case
The consensus narrative is that CNC is an expensive, illiquid micro-cap hardware company with lumpy revenue, execution risk, and no moat against billion-dollar competitors. The trailing P/E of 40x looks rich for a company doing £46m in revenue. Insiders have been selling—CEO Miles Adcock and CRO Brent Salgat both exercised options and sold shares in late 2025. The CFO is retiring. US defense budget delays and government shutdowns create order timing uncertainty. Competitive analysis from Koala Gains rates CNC as 'Underperform' versus Curtiss-Wright, Advantech, and even Mercury Systems—larger peers with vastly superior scale, R&D budgets, and global reach. The Systems business is still loss-making. Weekly volatility of 6.2% spooks institutional investors. With only 5-6 analysts covering the stock and average daily volume under 500k shares, this is essentially invisible to major funds. The market sees a small, cyclical defense hardware maker trading at premium multiples with concentrated customer risk (13% of revenue from a single customer).
The Bull Case
The market is dramatically underpricing the SOSA mandate structural shift. The US Department of Defense now REQUIRES open standards architecture for all new computing hardware—this breaks the vendor lock-in that protected incumbents like Curtiss-Wright and Abaco for decades. Concurrent's ENTIRE product portfolio is already SOSA-compliant. They're not catching up; they're ahead. FY25 design wins had an estimated lifetime value of £145m—roughly 3x annual revenue—providing massive multi-year visibility. These design wins convert to purchase orders within 2-3 years and generate revenue over 7-10 year product lifecycles. The balance sheet is a fortress: £14.4m net cash, ZERO debt, and a current ratio of 3.65x. This company cannot go bankrupt under any realistic scenario. Gross margins are expanding rapidly—from 49.4% to 53.3%—driven by procurement efficiencies and scale. The Systems business, acquired via Phillips Aerospace in 2023, is approaching breakeven and management targets it to match the Products business in size within 5 years. If achieved, that alone could double the company. Early access to Intel Xeon processors (6 months ahead of general availability) and the launch of Bragi with NVIDIA Blackwell architecture demonstrate deep partner relationships that smaller competitors cannot replicate. The Colchester factory expansion doubles capacity from ~£40m to ~£80m output for just £5m capex—an incredibly capital-efficient scale-up.
Fundamental Deep Dive
Balance Sheet Strength
Fortress-like. £14.4m net cash (up from £13.7m prior year) against zero debt. Cash represents approximately 6.5% of market capitalization. Operating cash flow of £7.0m in FY25 comfortably covers the £5.3m in investing activities and £1.0m in financing outflows, with cash still growing year-over-year. Current ratio of 3.65x provides enormous liquidity headroom. The company has a rolling credit facility for additional flexibility. Even under extreme stress testing (significant revenue decline, gross margin compression, reduced inventory drawdown), management confirms no borrowing requirement and no going concern uncertainty. This is a company that survives any macro environment and can self-fund its growth strategy without diluting shareholders.
Hidden Assets
The design win pipeline is the most underappreciated asset. FY25 alone secured £145m in estimated lifetime value from design wins, and cumulative design wins over 2023-2025 total approximately £345m. These are not speculative—they represent programs where Concurrent has already been down-selected and is awaiting contract award. The Philips Aerospace acquisition (September 2023) brought US defense accreditations, customer relationships, and engineering talent that are virtually impossible to replicate from scratch. Intel Prestige Partner status provides early processor access that competitors cannot match. The new Los Angeles facility and expanded Colchester manufacturing represent operational capacity that was paid for but whose revenue potential is largely unrealized. Capitalized development costs of £13.9m on the balance sheet represent a product portfolio generating current and future revenue with minimal additional investment required.
Revenue Stability
Defense programs create extraordinary revenue stickiness. Once a Concurrent board is designed into a mission-critical platform (submarine, aircraft, radar system), switching costs are prohibitively high—it can take years and millions of dollars to re-qualify a replacement component. Product lifecycles span 7-10 years minimum, with some VME architectures continuing for decades. FY25 order intake of £47m (a record, up 15%) provides strong near-term visibility. The Products business delivered £40.5m revenue with 57% gross margins and 17% operating profit margins—demonstrating the underlying profitability of the core franchise. Revenue is geographically diversified: US 52%, UK 9%, Italy 13%, Rest of Europe 13%, Asia-Pacific 13%. The growing design services revenue ($6.2m flagship contract) creates deeper customer engagement and higher switching costs.
Sentiment & Technical Setup
Short Interest
Short interest data is not readily available for AIM-listed stocks like CNC. The London Stock Exchange does not provide the same level of short interest transparency as US markets. However, the stock's characteristics—small float (~90.8m shares outstanding), limited institutional ownership, and average daily volume of ~459k shares—create conditions where any significant buying pressure could drive sharp price appreciation. There is no evidence of heavy short positioning, but the illiquidity itself creates squeeze-like dynamics when positive catalysts emerge, as seen in the 21% single-week rally in April 2026.
Institutional Positioning
Institutional ownership appears limited given the stock's AIM listing, small market cap (~£222m), and low trading liquidity. Only 5-6 analysts cover the stock (Berenberg, Cavendish, Investec). The average analyst price target of ~287p represents approximately 17.5% upside from the current 244p price. The bull case target of 385p implies 58% upside. The lack of institutional coverage creates both the opportunity (stock is mispriced) and the challenge (no natural buyer base to drive re-rating). CEO and CRO option exercises with partial share sales in late 2025 may have created negative sentiment among some followers, though both retained significant holdings post-transaction.
Retail Sentiment
Retail interest is growing but still nascent. The Motley Fool UK highlighted CNC as a 'surging ex-penny stock' for the defense spending revolution, noting the 233% gain from early 2024 levels. Simply Wall St community narratives are emerging around the SOSA structural thesis. Social media mentions remain limited compared to US defense names, but the story—small company disrupting entrenched defense incumbents through open standards—is the type of narrative that resonates with retail investors seeking the next defense sector winner. The stock's history as a former penny stock that has re-rated significantly creates a psychological anchor that may limit near-term enthusiasm, but also means the company is 'on the radar' of retail screeners for the first time.
Catalyst Analysis
Multiple near-term and medium-term catalysts exist. NEAR-TERM: (1) FY26 results exceeding market expectations of £52m revenue / £8m PBT—the company has a history of guiding conservatively and then beating, as seen in FY24 when revenue was ~10% ahead of expectations. (2) Systems business reaching profitability in FY26—management has indicated breakeven or better is expected, which would eliminate a drag on group margins and validate the Phillips Aerospace acquisition thesis. (3) Additional large contract announcements—the $6.2m design services contract demonstrates the company can win larger deals, and the pipeline is growing. MEDIUM-TERM: (4) Colchester factory expansion completion (H1 FY26) doubling capacity without production interruption—this removes the primary execution risk concern. (5) Continued design win announcements with large lifetime values reinforcing the revenue visibility narrative. (6) Potential M&A—the company has stated it is 'actively evaluating disciplined M&A opportunities' and has the balance sheet to execute. (7) Broader defense spending acceleration as NATO commitments translate into actual procurement—the lag between budget approval and order placement is shortening as urgency increases. (8) Analyst upgrades and initiation of coverage as the story becomes too compelling to ignore—currently only 5-6 analysts cover a company with £345m in cumulative design wins and a structural tailwind.
Key Risks
Primary Risk
Execution risk on the capacity expansion and systems scaling. The Colchester factory expansion and Systems business growth require flawless operational execution. Planning permission delays have already occurred (requiring an alternative, lower-cost approach). If Concurrent cannot deliver on its expanded order book due to production constraints, customers may lose patience and return to larger, more established suppliers. The SOSA advantage is a window of opportunity, not a permanent moat—if Concurrent fails to execute, incumbents will eventually transition their own product lines to open standards and the competitive advantage evaporates.
Secondary Risks
- US defense budget uncertainty and government shutdowns creating order delays—the FY25 results explicitly noted that US DoD budget approval delays and government shutdowns impacted Systems revenue growth, which came in below internal expectations despite the 157% increase.
- Customer and revenue concentration—a single customer represents 13% of revenue, and the US market represents 52% of total revenue. Any disruption to US defense procurement or loss of a key customer relationship would materially impact results.
- Valuation risk at 40x trailing P/E—the stock has already re-rated significantly from penny stock levels. Any earnings miss or guidance reduction could trigger a sharp de-rating, particularly given the limited liquidity and absence of strong institutional support.
- Competitive response from larger players—companies like Curtiss-Wright ($2.8B revenue) and Mercury Systems ($800M+ revenue) have vastly greater resources to develop SOSA-compliant products if they choose to prioritize this market aggressively.
What Would Change My Mind
I would reconsider the bullish thesis if: (1) The Systems business fails to reach profitability by mid-FY27, suggesting the Phillips Aerospace acquisition thesis is flawed. (2) Design win lifetime values decline significantly from the £145m achieved in FY25, indicating competitive pressure is eroding the SOSA advantage. (3) Gross margins contract below 50%, suggesting pricing power is weakening or procurement advantages are unsustainable. (4) The company undertakes a large, debt-funded acquisition that compromises the balance sheet fortress. (5) Key management departures beyond the planned CFO retirement suggest internal instability. (6) US defense budget cuts materialize that specifically target the types of modernization programs where Concurrent's products are specified.
Conclusion
The market is treating Concurrent Technologies as a cyclical small-cap defense hardware maker with lumpy revenue and no competitive moat. This fundamentally misunderstands the business. The SOSA mandate is not a temporary procurement preference—it's a structural shift in how the US Department of Defense buys computing hardware, explicitly designed to break the vendor lock-in that protected incumbents for decades. Concurrent is not a company trying to compete with Curtiss-Wright on scale; it's a company that has positioned itself exactly where the procurement winds are blowing, with an entirely SOSA-compliant product portfolio, early access to the latest Intel and NVIDIA processors, and deepening relationships with global defense primes. The £145m in FY25 design wins alone—roughly 3x annual revenue—represents a revenue pipeline that will convert to orders and then to revenue over the next 7-10 years. This is not speculative; these are programs where Concurrent has already been selected. The balance sheet provides the ultimate safety net: £14.4m net cash, zero debt, and self-funding operations mean this company survives any macro environment. The Systems business is approaching an inflection point from loss-making to profitability, which alone could drive meaningful margin expansion at the group level. The Colchester factory expansion doubles capacity for minimal capital outlay, positioning the company to capture the demand that its design wins are creating. At 244p, the stock trades at approximately 26-31x forward earnings depending on FY26 outcome—not cheap, but reasonable for a company with this level of revenue visibility, balance sheet strength, and structural tailwind. The risk-reward is asymmetric: the downside is protected by the cash position and the installed base of long-lifecycle products, while the upside is driven by design win conversion, Systems profitability, and the multi-year defense spending upcycle. The market has not yet connected the dots between the SOSA mandate, the design win pipeline, and the earnings power that will emerge as these programs move into production. When they do, this stock re-rates significantly.
Research Sources (19 found)
Final results for the year ended 31 December 2025 | Company Announcement | Investegate
Published: 4/13/2026
Concurrent Technologies reports double-digit growth | Financial News
Published: 4/13/2026
Concurrent Technologies (CNC) H2 2025 Summary | Quartr
Published: 4/17/2026
Conccurent Technologies - Final Results April 13, 2026
Published: 4/13/2026
Concurrent Technologies reports strong revenue, profit growth - Sharecast.com
Published: 1/20/2026
Concurrent Technologies plc (CNC) Competitive Analysis & Comparison (2026)
Published: 11/18/2025
Concurrent Technologies plc (CNC) Stock Analysis & Key Metrics (2026)
Published: 11/18/2025
Concurrent Revenue Rises On Record Orders
Published: 4/13/2026
Concurrent Technologies (AIM:CNC) - Stock Analysis - Simply Wall St
Published: 4/20/2026
Exercise of Options, Director Dealing and TVR | Company Announcement | Investegate
Published: 12/9/2025
Trading Update | Company Announcement | Investegate
Published: 1/20/2026
Concurrent Technologies (AIM:CNC) - Aktieanalys - Simply Wall St
Published: 5/11/2026
Concurrent Technologies Plc (COTGF) Discusses Full Year Results and Leadership Transition with Strategic Business Updates Transcript | Seeking Alpha
Published: 4/20/2026
A surging ex-penny stock to buy for the defence spending revolution? | The Motley Fool UK
Published: 3/7/2026
Which UK Stock Is Better: Tesco, Concurrent Technologies, or Churchill China?
Published: 4/21/2026
Concurrent Technologies Reports Record Order Intake and Strong FY25 Growth | Joshua Thompson
Published: 1/20/2026
CNC - Open Standards And Systems Expansion Will Support Long Term Defense Computing Upside
Published: 4/18/2026
Concurrent Technologies profits from growing military spending - Investors' Chronicle
Published: 4/14/2026
Concurrent unveils altered manufacturing proposals | MarketScreener
Published: 12/23/2025
Search Queries Generated
Concurrent Technologies Plc CNC.L quarterly earnings revenue growth profit margins
Concurrent Technologies Plc CNC.L market share competitive moat versus competitors
Concurrent Technologies Plc CNC.L management strategy capital allocation insider activity
Concurrent Technologies Plc CNC.L bear case analysis risks concerns headwinds
Concurrent Technologies Plc CNC.L industry trends catalysts defense electronics market
Peter Lynch
"Concurrent Technologies is a wonderful little business operating in a sweet spot of the defense market. They have the balance sheet Lynch loves (net cash) and operate in a boring industry he favors. However, the stock has already had a massive run (up 230%+ in two years), and the PEG ratio of 2.3 suggests the 'story' is already well known to the market. Peter Lynch taught us not to pay up for growth. With the P/E at 40x and receivables growing faster than sales, this is a 'Hold' if you own it, but not a 'Buy' at these prices. Wait for a pullback to get the PEG closer to 1.0 before buying into this defense story."
Overview
A comprehensive investment analysis of Concurrent Technologies Plc (CNC.L) using the philosophy of Peter Lynch, focusing on the business 'story', categorization, valuation via the PEG ratio, and balance sheet strength, to determine if this defense electronics specialist is a hidden gem or an expensive mistake.
The Two-Minute Story
Concurrent Technologies builds the rugged computer brains that go into military tanks, jets, and drones. With global defense spending rising and the military shifting to 'open standard' architectures (SOSA) that favor nimble specialists over big incumbents, Concurrent is winning record orders. They have no debt, a vault full of cash, and are doubling their factory size to meet demand. The story is simple: as wars get smarter, Concurrent sells the hardware that makes them smart.
Stock Category
Classification
Fast Grower
Category Reasoning
While the core 'Products' business grows steadily (6%), the 'Systems' division is exploding (157% revenue growth) and design services are gaining traction. With a small market cap (~£220m) and a clear runway in defense modernization, this fits the profile of a small company in a boring industry that is growing faster than the market realizes. The high P/E ratio also supports this classification.
Appropriate Expectations
Expect high volatility. If the growth story holds, the stock can multiply, but if the 'Systems' momentum stalls or the factory expansion hits snags, the high valuation will deflate rapidly. Investors should watch the earnings growth rate closely.
Do You Understand This Business?
Yes. They design and manufacture 'single-board computers'—essentially tough, specialized motherboards—that go into things like radar systems and submarines. While the average person doesn't buy these, the concept is understandable: they are the specialized 'nervous system' for heavy military machinery. My edge is recognizing the shift to the 'SOSA' open standard, which forces the military to buy off-the-shelf parts from companies like Concurrent rather than custom-built expensive systems from giants.
PEG Ratio Analysis
Current P/E
40.7 (Trailing), 26.6 (Forward)
Earnings Growth Rate
7% (Trailing EPS growth), ~17.8% (Analyst Forecast), ~22% (Implied by FY26 PBT guidance of £8m vs FY25 £6.5m)
PEG Ratio
2.3 (Using Trailing P/E 40.7 / 17.8% Growth) or 1.5 (Using Forward P/E 26.6 / 17.8% Growth)
PEG Interpretation
Expensive. Peter Lynch famously looked for a PEG ratio under 1.0, where the P/E is lower than the growth rate. Even using the optimistic forward P/E, the PEG is 1.5, suggesting the stock price has already run ahead of the current earnings growth. The market is paying a premium for the 'potential' of the Systems business and the order book conversion.
Lynch's Checklist
Boring and Overlooked?
Yes. Embedded computing for defense is not a sexy consumer trend. It is industrial and technical, keeping Wall Street hot money away.
Insider Buying?
Mixed/Negative. Insiders have been exercising options and selling shares. The CEO and CRO both sold shares to cover exercise costs, and the CFO is retiring. While option exercises show alignment, the net selling and retirement signal caution rather than aggressive conviction.
Balance Sheet Health
Excellent. The company has £14.4m in cash and zero debt. This is a classic Lynch positive—no leverage means no bankruptcy risk during a downturn.
Inventory and Receivables
Warning Sign. Trade receivables jumped from £6.2m to £9.6m (+55%) while revenue grew only 14%. This suggests they are selling on credit to boost sales or customers are paying slower, a red flag Lynch watched closely.
Room to Grow
High. The defense budget cycle is secular (NATO targets rising), and the SOSA mandate opens doors that were previously closed to small players. They are doubling factory capacity, indicating management sees years of demand ahead.
Tenbagger Potential
Unlikely from the current valuation. A 'tenbagger' from a £220m market cap would imply a £2.2bn company. While the defense sector can support large caps, Concurrent is a component supplier, not a platform builder. Competitors like Abaco sold for ~$1.35bn on ~$300m revenue. For CNC to 10x, they would likely need to be acquired at a massive premium or grow revenue 5-fold, which is a long shot for a hardware manufacturer. A 'double' is feasible if they execute on the order book, but a 10x is unrealistic.
Key Risks
Primary Risk
Valuation Risk. The stock is priced for perfection (P/E > 40). Any hiccup in the 'Systems' growth, a delay in US defense budget approvals (already flagged as an issue), or a failure to convert the record order book into cash will punish the share price severely.
Secondary Risks
- Execution Risk: Doubling factory capacity in Colchester and integrating the US acquisition is operationally complex.
- Customer Concentration: Revenue depends heavily on a few major defense primes and US government budget cycles.
What Would Change My Mind
If the 'Systems' business fails to reach profitability or if the rising receivables turn into bad debts, the 'Fast Grower' story collapses into a 'Stalwart' with a Stalwart's growth rate but a Fast Grower's price tag. I would also turn bearish if insider selling accelerates beyond option exercises.
Conclusion
Concurrent Technologies is a wonderful little business operating in a sweet spot of the defense market. They have the balance sheet Lynch loves (net cash) and operate in a boring industry he favors. However, the stock has already had a massive run (up 230%+ in two years), and the PEG ratio of 2.3 suggests the 'story' is already well known to the market. Peter Lynch taught us not to pay up for growth. With the P/E at 40x and receivables growing faster than sales, this is a 'Hold' if you own it, but not a 'Buy' at these prices. Wait for a pullback to get the PEG closer to 1.0 before buying into this defense story.
Research Sources (19 found)
Final results for the year ended 31 December 2025 | Company Announcement | Investegate
Published: 4/13/2026
Concurrent Technologies reports double-digit growth | Financial News
Published: 4/13/2026
Concurrent Technologies (CNC) H2 2025 Summary | Quartr
Published: 4/17/2026
Conccurent Technologies - Final Results April 13, 2026
Published: 4/13/2026
Concurrent Technologies reports strong revenue, profit growth - Sharecast.com
Published: 1/20/2026
Concurrent Technologies plc (CNC) Competitive Analysis & Comparison (2026)
Published: 11/18/2025
Concurrent Technologies plc (CNC) Stock Analysis & Key Metrics (2026)
Published: 11/18/2025
Concurrent Revenue Rises On Record Orders
Published: 4/13/2026
Concurrent Technologies (AIM:CNC) - Stock Analysis - Simply Wall St
Published: 4/20/2026
Exercise of Options, Director Dealing and TVR | Company Announcement | Investegate
Published: 12/9/2025
Trading Update | Company Announcement | Investegate
Published: 1/20/2026
Concurrent Technologies (AIM:CNC) - Aktieanalys - Simply Wall St
Published: 5/11/2026
Concurrent Technologies Plc (COTGF) Discusses Full Year Results and Leadership Transition with Strategic Business Updates Transcript | Seeking Alpha
Published: 4/20/2026
A surging ex-penny stock to buy for the defence spending revolution? | The Motley Fool UK
Published: 3/7/2026
Which UK Stock Is Better: Tesco, Concurrent Technologies, or Churchill China?
Published: 4/21/2026
Concurrent Technologies Reports Record Order Intake and Strong FY25 Growth | Joshua Thompson
Published: 1/20/2026
CNC - Open Standards And Systems Expansion Will Support Long Term Defense Computing Upside
Published: 4/18/2026
Concurrent Technologies profits from growing military spending - Investors' Chronicle
Published: 4/14/2026
Concurrent unveils altered manufacturing proposals | MarketScreener
Published: 12/23/2025
Search Queries Generated
Concurrent Technologies Plc CNC.L quarterly earnings revenue growth profit margins
Concurrent Technologies Plc CNC.L market share competitive moat versus competitors
Concurrent Technologies Plc CNC.L management strategy capital allocation insider activity
Concurrent Technologies Plc CNC.L bear case analysis risks concerns headwinds
Concurrent Technologies Plc CNC.L industry trends catalysts defense electronics market
Warren Buffett
"Concurrent Technologies is a wonderful business with a strong balance sheet and a durable niche in defense computing. The 'design-in' moat and SOSA compliance provide excellent revenue visibility. However, a wonderful business is rarely a wonderful investment at any price. At 244p, the stock is priced as a high-growth tech darling, yet the fundamentals—11% ROE and constrained free cash flow—resemble a cyclical industrial manufacturer. Buffett seeks a margin of safety; here, the market is offering a 'margin of danger.' Existing shareholders should hold the quality asset, but new capital should wait for the inevitable volatility of the defense cycle to present a better entry point."
Overview
A comprehensive investment analysis of Concurrent Technologies Plc (CNC.L) through the lens of Warren Buffett's value investing philosophy, evaluating the durability of its economic moat in defense computing, the quality of its balance sheet, and the margin of safety offered by its current market price.
Business Understanding
Concurrent Technologies designs and manufactures high-performance, ruggedized single-board computers and systems for mission-critical applications, primarily in defense, aerospace, and telecommunications. The business model is straightforward: Concurrent develops specialized hardware that is 'designed into' long-lifecycle military platforms (submarines, aircraft, ground vehicles). Once qualified, these products generate revenue for 7 to 10 years due to the extreme difficulty of replacing them. This is a simple, understandable business within the circle of competence of an investor familiar with industrial manufacturing and government contracting; it is not a complex 'black box' but a niche hardware supplier with a predictable revenue profile once design wins are secured.
Economic Moat Analysis
Concurrent possesses a narrow but durable economic moat based primarily on **high switching costs** and **intangible assets**. Once a Concurrent board is qualified for a military program—a process that takes years and costs millions—the customer cannot easily switch suppliers without re-qualifying the entire system, creating a captive revenue stream for the product's lifecycle (often a decade). Additionally, the company benefits from regulatory barriers (defense accreditations) and its 'Intel Prestige Partner' status, granting early access to processors (e.g., Xeon 6516P-B) that competitors lack. The strategic alignment with the SOSA open standard acts as both a sword and a shield: it disrupts incumbent proprietary systems but also opens the market to other competitors. The moat is durable but narrow; it relies on continued design wins rather than a monopolistic market position.
Management Quality
Management demonstrates a conservative, shareholder-friendly approach, particularly regarding capital allocation and the balance sheet. The company operates with zero debt and a cash pile of £14.4m (representing roughly 6.5% of market cap), providing a significant margin of safety against operational hiccups. The dividend has been consistently maintained and modestly increased (1.155p proposed for FY25), though the yield is negligible. However, there are yellow flags: the CEO exercised options and sold ~£154k of stock in late 2025, and the CFO is retiring, introducing succession risk. Additionally, management relies heavily on capitalizing development costs (£4.3m in FY25), which inflates accounting profits relative to cash flow generation.
Financial Strength
The balance sheet is the strongest feature of this business. With £14.4m in cash and zero debt, Concurrent is financially fortified against the macroeconomic and defense budget delays it cites as risks. Gross margins have expanded impressively to 53.3% (FY25), up from 49.4% in FY24, indicating pricing power and operational efficiency. However, Return on Equity (ROE) stands at a mediocre ~11.4% (£5.1m profit / £44.8m equity), suggesting that while the business is profitable, it is not a high-return-on-capital compounder. Furthermore, free cash flow is significantly lower than reported earnings due to heavy investment in capitalized development and working capital increases; FY25 saw operating cash flow of £7.0m but investing activities consumed £5.3m, leaving limited free cash flow for the current market cap.
Intrinsic Value Assessment
Based on FY25 earnings of £5.06m (EPS 5.86p) and a current price of 244p, the stock trades at a trailing P/E of ~41x and a forward P/E of ~26x (assuming EPS growth to ~9p). For a business with an ROE of 11% and lumpy, project-based revenue, a 40x multiple implies speculative growth expectations not supported by the current financials. Owner earnings (Net Income + D&A - CapEx - Working Capital changes) are significantly lower than reported profits due to the capitalization of R&D and inventory build-up. A conservative intrinsic value, using a 10% discount rate and modest growth, suggests the business is worth between £1.20 and £1.60 per share. At 244p, there is **no margin of safety**; the market has already priced in the successful conversion of the record order book and flawless execution of the Systems expansion.
Key Risks
Primary Risk
Valuation Risk: The current market price (244p) prices in perfection. Any delay in the conversion of design wins to revenue, or a miss on the £8m PBT forecast for FY26, could lead to a severe de-rating of the stock.
Secondary Risks
- Customer Concentration and Budget Risk: Over 50% of revenue is US-based, exposing the company to US Department of Defense budget delays and government shutdowns, as explicitly noted by management.
- Execution Risk on Capacity: The company is doubling manufacturing capacity in Colchester. If demand falters or the transition is mismanaged, the higher fixed cost base will compress margins.
- Technological Obsolescence: While SOSA is a current tailwind, the shift to open standards ultimately lowers barriers to entry, allowing larger, lower-cost competitors (like Advantech or Curtiss-Wright) to compete more directly on future programs.
What Would Change My Mind
A significant correction in the share price to below 150p (P/E ~25x trailing), which would provide a margin of safety relative to the current growth rate, or evidence that the Systems division can sustainably achieve gross margins comparable to the Products division (57%) without the drag of design services costs.
Investment Details
Hold Period
5-10 years
Research Sources (19 found)
Final results for the year ended 31 December 2025 | Company Announcement | Investegate
Published: 4/13/2026
Concurrent Technologies reports double-digit growth | Financial News
Published: 4/13/2026
Concurrent Technologies (CNC) H2 2025 Summary | Quartr
Published: 4/17/2026
Conccurent Technologies - Final Results April 13, 2026
Published: 4/13/2026
Concurrent Technologies reports strong revenue, profit growth - Sharecast.com
Published: 1/20/2026
Concurrent Technologies plc (CNC) Competitive Analysis & Comparison (2026)
Published: 11/18/2025
Concurrent Technologies plc (CNC) Stock Analysis & Key Metrics (2026)
Published: 11/18/2025
Concurrent Revenue Rises On Record Orders
Published: 4/13/2026
Concurrent Technologies (AIM:CNC) - Stock Analysis - Simply Wall St
Published: 4/20/2026
Exercise of Options, Director Dealing and TVR | Company Announcement | Investegate
Published: 12/9/2025
Trading Update | Company Announcement | Investegate
Published: 1/20/2026
Concurrent Technologies (AIM:CNC) - Aktieanalys - Simply Wall St
Published: 5/11/2026
Concurrent Technologies Plc (COTGF) Discusses Full Year Results and Leadership Transition with Strategic Business Updates Transcript | Seeking Alpha
Published: 4/20/2026
A surging ex-penny stock to buy for the defence spending revolution? | The Motley Fool UK
Published: 3/7/2026
Which UK Stock Is Better: Tesco, Concurrent Technologies, or Churchill China?
Published: 4/21/2026
Concurrent Technologies Reports Record Order Intake and Strong FY25 Growth | Joshua Thompson
Published: 1/20/2026
CNC - Open Standards And Systems Expansion Will Support Long Term Defense Computing Upside
Published: 4/18/2026
Concurrent Technologies profits from growing military spending - Investors' Chronicle
Published: 4/14/2026
Concurrent unveils altered manufacturing proposals | MarketScreener
Published: 12/23/2025
Search Queries Generated
Concurrent Technologies Plc CNC.L quarterly earnings revenue growth profit margins
Concurrent Technologies Plc CNC.L market share competitive moat versus competitors
Concurrent Technologies Plc CNC.L management strategy capital allocation insider activity
Concurrent Technologies Plc CNC.L bear case analysis risks concerns headwinds
Concurrent Technologies Plc CNC.L industry trends catalysts defense electronics market
William O'Neil
"Concurrent Technologies is a high-quality niche player benefiting from a secular shift (SOSA) and a cyclical upturn (Defense spending). The CAN SLIM analysis reveals a company with strong momentum and product leadership. However, the current EPS growth rate (7%) does not meet the strict O'Neil threshold of 25%+, and the stock's valuation is stretched (Trailing P/E > 40x). While the future forecast is strong, the stock has already discounted much of this success. The transition from a 'Products' only house to a 'Products + Systems' house introduces execution risk. Therefore, while the fundamental business is excellent, the stock is a HOLD—worth holding for the long-term design win conversion but too risky to initiate a large new position at this extended valuation without a pullback to the 50-day moving average or better confirmation of earnings acceleration in H1 2026."
Overview
This report provides a comprehensive investment analysis of Concurrent Technologies Plc (CNC.L) using William J. O'Neil's CAN SLIM methodology. It evaluates the company's earnings growth, new product catalysts, supply/demand dynamics, institutional sponsorship, and market direction to determine the stock's potential for significant price appreciation.
Financial and Business Overview
Concurrent Technologies Plc is a UK-based designer and manufacturer of high-performance, ruggedized embedded computer products and systems. The company serves mission-critical markets, primarily defense and aerospace, where reliability and longevity are paramount. In FY25, the company reported revenue of £45.9 million (+14% YoY) and Profit Before Tax (PBT) of £6.5 million (+25% YoY), with a record order intake of £47 million (+15%). The balance sheet is robust, characterized by a net cash position of £14.4 million and zero debt. The business operates two units: Products (stable, high-margin) and Systems (high-growth, lower-margin currently but scaling). The company benefits from a structural shift towards open standards (SOSA) in defense procurement and rising global defense budgets.
Market Position & Competitive Advantages
Concurrent Technologies occupies a specialized niche in the defense electronics supply chain. Its primary competitive advantage is its early alignment with the Sensor Open Systems Architecture (SOSA) mandate, which forces defense primes to move away from proprietary systems, allowing agile specialists like Concurrent to win designs previously locked up by larger incumbents. The company benefits from high switching costs; once its boards are 'designed in' to a long-lifecycle defense platform (often 7-10 years), it is prohibitively expensive for customers to switch. Additionally, Concurrent boasts a pristine balance sheet (net cash) and Intel 'Prestige Partner' status, granting early access to next-gen processors. The main competitive disadvantage is its small scale compared to giants like Curtiss-Wright or Abaco, limiting its R&D budget and ability to bid on the largest prime contracts independently. However, its focus on niche, high-performance computing allows it to maintain margins (Products gross margin 57%) that often exceed larger peers.
Stock Performance
The stock has experienced a significant re-rating, moving from penny stock territory (around 81p in early 2024) to over 270p recently, a gain of over 200%. As of the latest data, the price sits at 244.12p. It is trading above both its 50-day (218.42p) and 200-day (225.77p) moving averages, indicating a strong uptrend. The stock is approximately 12% off its 52-week high of 278p. Volume has been robust, supporting the price advance, though recent trading shows some volatility with the stock pulling back on the day of the full-year results announcement. The 1-year return is approximately 32-50% depending on the exact data point, significantly outperforming the broader UK market and tech sector.
CAN SLIM Analysis
Current Quarterly Earnings Per Share (EPS) Growth:
The most recent full-year results (FY25) show EPS growth of 7% (5.86p vs 5.49p). However, Profit Before Tax grew 25%, and the first half of 2025 showed stronger momentum. The EPS growth rate is currently below the O'Neil ideal of 25%+, largely due to increased investment and share dilution, but the acceleration in order intake and PBT suggests improving fundamentals. The forecast for FY26 implies a significant acceleration in earnings growth to around 17-20% based on analyst targets (£8m PBT vs £6.5m).
Annual Earnings Increases:
The 5-year earnings history shows high volatility. Earnings declined significantly in FY22 (recovery from a low base) but have since rebounded strongly. The 3-year CAGR for EPS is high (approx. 37%) due to the recovery cycle, but the longer 5-year trend is less consistent. Return on Equity (ROE) is currently around 12-13%, which is moderate but improving, supported by the debt-free balance sheet.
New Products, Management, or Price Highs:
Concurrent scores high here. It has launched multiple new products including 'Kratos' (Intel Xeon based), 'Bragi' (NVIDIA Blackwell based), and 'Apollo' (rugged system). These products align perfectly with the SOSA transition. The company recently secured its largest-ever contract ($6.2m) in Design Services. Management has expanded capacity (new LA facility, Colchester expansion) to meet demand. The stock recently hit a 52-week high of 278p, showing market recognition of these catalysts.
Supply and Demand:
The 'Supply' is tight with approximately 90.8 million shares outstanding and a market cap of ~£222 million. Average daily volume is around 450,000 shares, providing decent liquidity for an AIM stock. The 'Demand' side shows signs of accumulation; the stock has risen significantly, and institutional ownership is present. However, there has been some insider selling by directors (CEO and CRO exercising options and selling portions), which is typical for small-cap executives but warrants monitoring. The record order book suggests fundamental demand for the product is outstripping supply capacity, prompting the factory expansion.
Leader or Laggard:
Concurrent is a clear Leader in its specific sub-niche of SOSA-aligned VPX computing. Its revenue growth and stock performance have dramatically outpaced the broader UK market and many tech peers over the last 1-3 years. It is capitalizing on the defense upcycle faster than larger, slower-moving competitors. Relative strength is strong, although the recent pullback from highs requires watching.
Institutional Sponsorship:
The stock is covered by several analysts (Berenberg, Cavendish, Investec) with a consensus 'Buy' rating. Institutional ownership includes pension funds and small-cap specialists. The recent re-rating suggests increasing institutional interest. However, as an AIM-listed micro-cap, it does not have the massive sponsorship of a FTSE 100 name. The CFO's retirement announcement might cause short-term uncertainty among holders.
Market Direction:
The general UK market has been mixed but has shown resilience. The specific sector (Defense/Tech) is in a confirmed uptrend due to geopolitical tailwinds. The market direction for defense stocks specifically is very favorable, acting as a tailwind for CNC.
Key Risks
Primary Risk
Execution Risk on Capacity Expansion: The company is doubling manufacturing capacity, but planning delays have already occurred. Failure to deliver on time could result in lost orders or damaged relationships with new primes, jeopardizing the 'first mover' SOSA advantage.
Secondary Risks
- US Defense Budget Timing: The company noted delays due to the US government shutdown. Prolonged political gridlock could delay contract conversions from design wins to revenue.
- Valuation Risk: The stock trades at a high Forward P/E (approx. 26-30x) and Trailing P/E (approx. 40x), pricing in significant future growth. Any slowdown in order intake could lead to a sharp de-rating.
- Margin Pressure: The Systems business has lower margins than Products. As the mix shifts, group margins could be diluted if scale efficiencies are not realized.
What Would Change My Mind
A significant miss on order intake or a downgrade in the order book conversion rate would invalidate the growth thesis. Additionally, if the Colchester capacity expansion faces further material delays or if US defense spending is materially cut, the outlook would weaken substantially. A break below the 200-day moving average on high volume would be a technical sell signal.
Conclusion
Concurrent Technologies is a high-quality niche player benefiting from a secular shift (SOSA) and a cyclical upturn (Defense spending). The CAN SLIM analysis reveals a company with strong momentum and product leadership. However, the current EPS growth rate (7%) does not meet the strict O'Neil threshold of 25%+, and the stock's valuation is stretched (Trailing P/E > 40x). While the future forecast is strong, the stock has already discounted much of this success. The transition from a 'Products' only house to a 'Products + Systems' house introduces execution risk. Therefore, while the fundamental business is excellent, the stock is a HOLD—worth holding for the long-term design win conversion but too risky to initiate a large new position at this extended valuation without a pullback to the 50-day moving average or better confirmation of earnings acceleration in H1 2026.
Research Sources (19 found)
Final results for the year ended 31 December 2025 | Company Announcement | Investegate
Published: 4/13/2026
Concurrent Technologies reports double-digit growth | Financial News
Published: 4/13/2026
Concurrent Technologies (CNC) H2 2025 Summary | Quartr
Published: 4/17/2026
Conccurent Technologies - Final Results April 13, 2026
Published: 4/13/2026
Concurrent Technologies reports strong revenue, profit growth - Sharecast.com
Published: 1/20/2026
Concurrent Technologies plc (CNC) Competitive Analysis & Comparison (2026)
Published: 11/18/2025
Concurrent Technologies plc (CNC) Stock Analysis & Key Metrics (2026)
Published: 11/18/2025
Concurrent Revenue Rises On Record Orders
Published: 4/13/2026
Concurrent Technologies (AIM:CNC) - Stock Analysis - Simply Wall St
Published: 4/20/2026
Exercise of Options, Director Dealing and TVR | Company Announcement | Investegate
Published: 12/9/2025
Trading Update | Company Announcement | Investegate
Published: 1/20/2026
Concurrent Technologies (AIM:CNC) - Aktieanalys - Simply Wall St
Published: 5/11/2026
Concurrent Technologies Plc (COTGF) Discusses Full Year Results and Leadership Transition with Strategic Business Updates Transcript | Seeking Alpha
Published: 4/20/2026
A surging ex-penny stock to buy for the defence spending revolution? | The Motley Fool UK
Published: 3/7/2026
Which UK Stock Is Better: Tesco, Concurrent Technologies, or Churchill China?
Published: 4/21/2026
Concurrent Technologies Reports Record Order Intake and Strong FY25 Growth | Joshua Thompson
Published: 1/20/2026
CNC - Open Standards And Systems Expansion Will Support Long Term Defense Computing Upside
Published: 4/18/2026
Concurrent Technologies profits from growing military spending - Investors' Chronicle
Published: 4/14/2026
Concurrent unveils altered manufacturing proposals | MarketScreener
Published: 12/23/2025
Search Queries Generated
Concurrent Technologies Plc CNC.L quarterly earnings revenue growth profit margins
Concurrent Technologies Plc CNC.L market share competitive moat versus competitors
Concurrent Technologies Plc CNC.L management strategy capital allocation insider activity
Concurrent Technologies Plc CNC.L bear case analysis risks concerns headwinds
Concurrent Technologies Plc CNC.L industry trends catalysts defense electronics market
Stanley Druckenmiller
"Concurrent Technologies offers a rare exposure to a structural shift in defense procurement (SOSA) combined with a specific product advantage (Intel/Nvidia early access). The financial profile—net cash, rising margins, and a massive design win pipeline—fits the Druckenmiller criteria of a company capitalizing on a macro trend with a strong balance sheet. While the valuation is stretched on a trailing basis, the forward P/E of 26.6x compresses rapidly if FY26 estimates (£52m revenue, £8m PBT) are met or exceeded. The reflexivity of the design win cycle suggests earnings power is likely to surprise to the upside as programs transition to production. This is a 'trend rider' position where the secular tailwind justifies the premium."
Overview
A top-down macro and reflexive analysis of Concurrent Technologies Plc (CNC.L), focusing on the intersection of structural defense spending increases, the secular shift to open-architecture computing (SOSA), and the company's positioning to capture disproportionate market share from established incumbents.
Macro Context
We are in the early innings of a structural upcycle in global defense spending, driven by geopolitical realignments (NATO commitments, Ukraine conflict) and the obsolescence of proprietary military hardware. While broader economic cycles face headwinds from sticky inflation and central bank uncertainty, the defense sector operates on a different, multi-year fiscal cycle that is accelerating. Concurrently, a secular technological shift towards 'Open Systems Architecture' (SOSA) is disrupting the defense hardware market, breaking vendor lock-in and favoring agile, standards-compliant specialists over legacy incumbents burdened by technical debt. In this environment, cash-rich, debt-free companies hold a distinct advantage in navigating supply chain volatility.
Company Position in Macro Landscape
Concurrent Technologies is a direct beneficiary of these macro tailwinds. It sits at the nexus of rising defense budgets and the SOSA mandate. Unlike larger peers who must cannibalize legacy revenue streams to adopt open standards, CNC’s entire product portfolio is aligned with SOSA/VPX, making it a 'pure play' on the standard's adoption. Furthermore, with £14.4m in net cash and no debt, the company is structurally insulated from the high-interest-rate environment that constrains leveraged competitors, allowing it to fund R&D (capitalizing £3.9m in FY25) and capacity expansion internally.
Reflexivity Analysis
A powerful positive feedback loop is forming: The SOSA mandate opens contracts previously locked by incumbents -> CNC wins design-ins (record £145m lifetime value in FY25) -> Increased revenue and margins (PBT +25%) -> Higher cash generation -> Reinvestment in R&D and capacity (Colchester/LA expansion) -> Stronger product offering (Early Intel/Nvidia access) -> More design wins. The reflexivity extends to market perception; as the 'SOSA standard bearer,' CNC's stock becomes a proxy for the defense modernization theme, attracting capital inflows that validate the growth narrative, though this also raises the risk of multiple compression if conversion lags.
Competitive Position & Disruptive Threats
CNC operates as a focused specialist against industrial giants (Curtiss-Wright, Mercury Systems). While competitors have scale, CNC has agility and a pristine balance sheet. The competitive moat is defined by 'designed-in' status; once a board is qualified for a defense platform, switching costs are prohibitive. The disruptive threat comes not from technology, but from execution: if CNC fails to scale manufacturing capacity (Colchester delays noted in late 2025), it risks losing the 'first mover' advantage in SOSA, allowing incumbents time to catch up. However, strategic partnerships with Intel (Prestige Partner) and Nvidia mitigate product obsolescence risk.
Asymmetric Risk/Reward
The asymmetry is skewed to the upside based on the conversion of the design win pipeline. The market cap is ~£222m, yet the FY25 design wins have a lifetime value of £145m. If the Systems business scales as projected (targeting parity with Products in 5 years), the profit leverage is substantial given the shift from custom design (16% margin) to production (57% gross margin in Products). The downside is protected by the cash buffer and sticky defense revenue. Entry point is the primary concern; the stock has re-rated significantly from penny-stock levels, trading at a trailing P/E of ~41x. The risk/reward is attractive only if one believes the 'lumpy' revenue stream will smooth out as the pipeline converts.
Key Risks
Primary Risk
Execution Risk on Capacity Expansion: The Colchester factory relocation and expansion are critical to fulfilling the growing order book. Planning delays have already occurred; failure to deliver capacity on time could result in order leakage to competitors.
Secondary Risks
- US Budget Timing: US DoD budget delays and government shutdowns create near-term lumpiness in order intake and revenue recognition, as seen in FY25.
- Valuation: The stock trades at a premium (Forward P/E ~26.6x), pricing in significant growth. Any miss on design win conversion or margin expansion could trigger a sharp de-rating.
What Would Change My Mind
A significant slowdown in order intake or a loss of major design-in contracts to incumbents would signal that the SOSA tailwind is weakening or that scale is overpowering agility. Additionally, if the Systems business fails to move toward breakeven/profitability by FY26, the thesis on margin expansion collapses.
Investment Details
Sizing Recommendation
Medium
Time Horizon
1-2 years
Key Catalyst
Conversion of the £145m design win pipeline into production revenue, specifically evidenced by a breakout in Systems revenue and margin improvement in H1/FY26 results.
Research Sources (19 found)
Final results for the year ended 31 December 2025 | Company Announcement | Investegate
Published: 4/13/2026
Concurrent Technologies reports double-digit growth | Financial News
Published: 4/13/2026
Concurrent Technologies (CNC) H2 2025 Summary | Quartr
Published: 4/17/2026
Conccurent Technologies - Final Results April 13, 2026
Published: 4/13/2026
Concurrent Technologies reports strong revenue, profit growth - Sharecast.com
Published: 1/20/2026
Concurrent Technologies plc (CNC) Competitive Analysis & Comparison (2026)
Published: 11/18/2025
Concurrent Technologies plc (CNC) Stock Analysis & Key Metrics (2026)
Published: 11/18/2025
Concurrent Revenue Rises On Record Orders
Published: 4/13/2026
Concurrent Technologies (AIM:CNC) - Stock Analysis - Simply Wall St
Published: 4/20/2026
Exercise of Options, Director Dealing and TVR | Company Announcement | Investegate
Published: 12/9/2025
Trading Update | Company Announcement | Investegate
Published: 1/20/2026
Concurrent Technologies (AIM:CNC) - Aktieanalys - Simply Wall St
Published: 5/11/2026
Concurrent Technologies Plc (COTGF) Discusses Full Year Results and Leadership Transition with Strategic Business Updates Transcript | Seeking Alpha
Published: 4/20/2026
A surging ex-penny stock to buy for the defence spending revolution? | The Motley Fool UK
Published: 3/7/2026
Which UK Stock Is Better: Tesco, Concurrent Technologies, or Churchill China?
Published: 4/21/2026
Concurrent Technologies Reports Record Order Intake and Strong FY25 Growth | Joshua Thompson
Published: 1/20/2026
CNC - Open Standards And Systems Expansion Will Support Long Term Defense Computing Upside
Published: 4/18/2026
Concurrent Technologies profits from growing military spending - Investors' Chronicle
Published: 4/14/2026
Concurrent unveils altered manufacturing proposals | MarketScreener
Published: 12/23/2025
Search Queries Generated
Concurrent Technologies Plc CNC.L quarterly earnings revenue growth profit margins
Concurrent Technologies Plc CNC.L market share competitive moat versus competitors
Concurrent Technologies Plc CNC.L management strategy capital allocation insider activity
Concurrent Technologies Plc CNC.L bear case analysis risks concerns headwinds
Concurrent Technologies Plc CNC.L industry trends catalysts defense electronics market
Joel Greenblatt
"Concurrent Technologies is a fantastic business with high returns on capital and a strong strategic position in defense electronics. However, Joel Greenblatt's Magic Formula demands that we buy these good businesses only when they are cheap. At an earnings yield of 3.2% and a P/E of 41x, this stock is expensive. It offers a lower yield than risk-free government bonds, violating the core principle of buying with a margin of safety. While the growth story is compelling, the price has run ahead of the normalized earnings power. A disciplined Magic Formula investor would sell or rotate capital into cheaper, higher-yielding opportunities."
Overview
This report analyzes Concurrent Technologies Plc (CNC.L) through the lens of Joel Greenblatt's Magic Formula. The Magic Formula seeks to identify 'good companies' that generate high returns on capital (buying quality) trading at 'cheap prices' relative to their earnings power (buying value). We rank the stock based on its Earnings Yield (EBIT/Enterprise Value) and Return on Capital (EBIT/Invested Capital) to determine if it fits a systematic, value-driven investment strategy.
Business Quality Assessment
Concurrent Technologies is a very high-quality business. Using Greenblatt's strict definition of Invested Capital (Net Working Capital + Net Fixed Assets), the Return on Capital (ROC) is approximately 36.9%. This is calculated as EBIT of £6.63m divided by Invested Capital of £17.98m (£13.31m Net Working Capital + £4.67m Net Fixed Assets). The company benefits from high switching costs; once its boards are 'designed in' to long-lifecycle defense platforms, customers rarely switch. The asset-light model (excluding capitalized development costs from tangible invested capital) and net cash balance sheet amplify the high returns. Historically, returns have been volatile but the structural shift toward SOSA standards and increased defense spending has solidified this high-return profile.
Valuation Analysis
The stock is expensive based on the Magic Formula's Earnings Yield metric. The Earnings Yield is approximately 3.2%, calculated as EBIT (£6.63m) divided by Enterprise Value (£207.39m). The Enterprise Value is derived from the Market Cap (£221.76m) minus Net Cash (£14.37m), as the company holds no debt. A 3.2% earnings yield is significantly below the risk-free rate offered by UK gilts and far below the threshold typically required by the Magic Formula (which usually targets yields above 6-8%). Even using forward consensus EBIT estimates of ~£8.5m (based on FY26 PBT expectations of £8.0m), the forward earnings yield is roughly 4.1%, which remains unattractively low.
Magic Formula Ranking
Earnings Yield Score
Bottom Quartile. With an earnings yield of ~3.2%, the stock ranks very low on cheapness. It is priced as a growth stock, not a value stock.
Return on Capital Score
Top Decile. With an ROC of ~36.9% (or ~19% if including intangible assets), the business ranks exceptionally high on quality and capital efficiency.
Combined Assessment
No. This stock would almost certainly not rank in the top decile for the combined Magic Formula screen. While the quality (ROC) is top-tier, the valuation (EY) is bottom-tier. The Magic Formula requires both criteria to be met; paying too much for a good business violates the 'cheapness' principle.
Normalized Earnings Analysis
Current reported EBIT of £6.63m appears to be a sustainable normalized run rate, representing a steady state of the current defense cycle. However, earnings are 'lumpy' due to the project-based nature of defense contracts and the timing of design wins converting to production orders. There are no significant one-time items distorting the current figure, though there is a small exceptional item (-£0.15m) and share-based payments included. The key question is whether the market is extrapolating a linear continuation of the recent 25% profit growth. The normalized owner earnings power is solid, but the current share price implies a continuation of high growth that is not guaranteed.
Why The Market Is Wrong
In this case, the market is likely not 'wrong' about the quality of the business, but it is pricing the stock for perfection. The contrarian case here is that the market is over-extrapolating the defense spending 'super-cycle' and the SOSA transition. While Concurrent is a clear winner in this niche, the current valuation (P/E ~41x trailing) leaves no margin of safety. If US defense budget approvals continue to lag (as seen in the recent government shutdown delays) or if competitors catch up on SOSA compliance faster than expected, the growth multiple will contract. The Magic Formula specifically avoids stocks that require heroic growth assumptions; this stock currently requires them to justify its price.
Key Risks
Primary Risk
Valuation/Overpayment Risk. With an earnings yield of only 3.2%, the margin of safety is virtually non-existent. Any deceleration in growth or failure to meet market expectations of £8.0m PBT for FY26 will likely result in a significant share price de-rating.
Secondary Risks
- Execution Risk in Capacity Expansion: The company is attempting to double manufacturing capacity at Colchester. Planning delays have already occurred; further missteps could restrict the ability to fulfill the record order book.
- US Defense Budget Timing: Heavy reliance on US defense primes means the company is exposed to the political cycle and government shutdowns, which caused order delays in FY25.
What Would Change My Mind
A significant correction in the share price. If the market cap were to fall such that the Earnings Yield rose to at least 6-7% (implying a share price roughly 50% lower), the stock would become a compelling Magic Formula buy. Alternatively, a sustained increase in profitability that pushes the EBIT high enough to create a high Earnings Yield at the current price.
Conclusion
Concurrent Technologies is a fantastic business with high returns on capital and a strong strategic position in defense electronics. However, Joel Greenblatt's Magic Formula demands that we buy these good businesses only when they are cheap. At an earnings yield of 3.2% and a P/E of 41x, this stock is expensive. It offers a lower yield than risk-free government bonds, violating the core principle of buying with a margin of safety. While the growth story is compelling, the price has run ahead of the normalized earnings power. A disciplined Magic Formula investor would sell or rotate capital into cheaper, higher-yielding opportunities.
Research Sources (19 found)
Final results for the year ended 31 December 2025 | Company Announcement | Investegate
Published: 4/13/2026
Concurrent Technologies reports double-digit growth | Financial News
Published: 4/13/2026
Concurrent Technologies (CNC) H2 2025 Summary | Quartr
Published: 4/17/2026
Conccurent Technologies - Final Results April 13, 2026
Published: 4/13/2026
Concurrent Technologies reports strong revenue, profit growth - Sharecast.com
Published: 1/20/2026
Concurrent Technologies plc (CNC) Competitive Analysis & Comparison (2026)
Published: 11/18/2025
Concurrent Technologies plc (CNC) Stock Analysis & Key Metrics (2026)
Published: 11/18/2025
Concurrent Revenue Rises On Record Orders
Published: 4/13/2026
Concurrent Technologies (AIM:CNC) - Stock Analysis - Simply Wall St
Published: 4/20/2026
Exercise of Options, Director Dealing and TVR | Company Announcement | Investegate
Published: 12/9/2025
Trading Update | Company Announcement | Investegate
Published: 1/20/2026
Concurrent Technologies (AIM:CNC) - Aktieanalys - Simply Wall St
Published: 5/11/2026
Concurrent Technologies Plc (COTGF) Discusses Full Year Results and Leadership Transition with Strategic Business Updates Transcript | Seeking Alpha
Published: 4/20/2026
A surging ex-penny stock to buy for the defence spending revolution? | The Motley Fool UK
Published: 3/7/2026
Which UK Stock Is Better: Tesco, Concurrent Technologies, or Churchill China?
Published: 4/21/2026
Concurrent Technologies Reports Record Order Intake and Strong FY25 Growth | Joshua Thompson
Published: 1/20/2026
CNC - Open Standards And Systems Expansion Will Support Long Term Defense Computing Upside
Published: 4/18/2026
Concurrent Technologies profits from growing military spending - Investors' Chronicle
Published: 4/14/2026
Concurrent unveils altered manufacturing proposals | MarketScreener
Published: 12/23/2025
Search Queries Generated
Concurrent Technologies Plc CNC.L quarterly earnings revenue growth profit margins
Concurrent Technologies Plc CNC.L market share competitive moat versus competitors
Concurrent Technologies Plc CNC.L management strategy capital allocation insider activity
Concurrent Technologies Plc CNC.L bear case analysis risks concerns headwinds
Concurrent Technologies Plc CNC.L industry trends catalysts defense electronics market